Meda Pharmaceuticals Company Description
You won't turn your nose up at Meda Pharmaceuticals (formerly MedPointe) products, especially if you've got a runny one. The specialty drug firm makes a number of prescription remedies for colds and allergies, including its flagship product, Astelin nasal spray antihistamine. Meda makes therapies in other niche markets, such as central nervous system disorders -- its Felbatrol treats epilepsy -- and it is looking to expand into other areas such as women's health and dermatology. Its sales force targets doctors and hospitals in the US. In 2007 Swedish drug firm Meda AB acquired the company from a group of private equity firms; its name was changed from MedPointe to Meda Pharmaceuticals in 2008.
View the Comprehensive Company Description for Meda Pharmaceuticals
The Company Description provides a historical perspective of Meda Pharmaceuticals's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Meda Pharmaceuticals's evolution in the marketplace.
